Publications by the researcher in collaboration with Tomas Sobrino Moreiras (48)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  3. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  4. sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 171-180

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  3. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  4. STWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 528-535

  5. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

  6. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. Antihyperthermic treatment decreases perihematomal hypodensity

    Neurology, Vol. 94, Núm. 16, pp. E1738-E1748

  2. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

  3. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack

    International Journal of Cardiology, Vol. 298, pp. 93-97

  4. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  5. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2019

  1. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia

    EBioMedicine, Vol. 39, pp. 118-131

  2. Light-emitting diode photobiomodulation after cerebral ischemia

    Frontiers in Neurology, Vol. 10, Núm. AUG

  3. Multifunctional superparamagnetic stiff nanoreservoirs for blood brain barrier applications

    Nanomaterials, Vol. 9, Núm. 3